Search research articles
Contact Us
Filters
Showing results (81-90 of 281) with videos related to
Page
of 29
Sort By:
British Journal of Cancer
|
March 10, 2022
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer
Gianluca Mauri, Pietro Paolo Vitiello, Alberto Sogari, et al.
Briefings in Bioinformatics
|
May 24, 2024
Mutational signatures of colorectal cancers according to distinct computational workflows
Paolo Battuello, Giorgio Corti, Alice Bartolini, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 29, 2011
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia
Alessia Bottos, Miriam Martini, Federica Di Nicolantonio, et al.
Cancers
|
March 10, 2022
Inhibition of Heme Export and/or Heme Synthesis Potentiates Metformin Anti-Proliferative Effect on Cancer Cell Lines
Anna Lucia Allocco, Francesca Bertino, Sara Petrillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2014
Circulating pEGFR is a candidate response biomarker of cetuximab therapy in colorectal cancer
Theodora Katsila, Mercè Juliachs, Josep Gregori, et al.
The Lancet. Oncology
|
May 3, 2005
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
Mauro Moroni, Silvio Veronese, Silvia Benvenuti, et al.
Nature Communications
|
June 9, 2017
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
Moiez Ali, Erin Kaltenbrun, Gray R Anderson, et al.
Nature
|
January 28, 2012
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad, Chong Sun, Sidong Huang, et al.
Cancer Treatment Reviews
|
November 5, 2013
Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities
Angela Esposito, Alberto Bardelli, Carmen Criscitiello, et al.
Cancers
|
September 13, 2025
KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open Challenges
Pietro Paolo Vitiello, Anna Amela Valsecchi, Eleonora Duregon, et al.
Page
of 29
Search research articles
Search
Showing results (81-90 of 281) with videos related to
Sort By:
Page
of 29
British Journal of Cancer
|
March 10, 2022
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer
Gianluca Mauri, Pietro Paolo Vitiello, Alberto Sogari, et al.
Briefings in Bioinformatics
|
May 24, 2024
Mutational signatures of colorectal cancers according to distinct computational workflows
Paolo Battuello, Giorgio Corti, Alice Bartolini, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 29, 2011
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia
Alessia Bottos, Miriam Martini, Federica Di Nicolantonio, et al.
Cancers
|
March 10, 2022
Inhibition of Heme Export and/or Heme Synthesis Potentiates Metformin Anti-Proliferative Effect on Cancer Cell Lines
Anna Lucia Allocco, Francesca Bertino, Sara Petrillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2014
Circulating pEGFR is a candidate response biomarker of cetuximab therapy in colorectal cancer
Theodora Katsila, Mercè Juliachs, Josep Gregori, et al.
The Lancet. Oncology
|
May 3, 2005
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
Mauro Moroni, Silvio Veronese, Silvia Benvenuti, et al.
Nature Communications
|
June 9, 2017
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
Moiez Ali, Erin Kaltenbrun, Gray R Anderson, et al.
Nature
|
January 28, 2012
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad, Chong Sun, Sidong Huang, et al.
Cancer Treatment Reviews
|
November 5, 2013
Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities
Angela Esposito, Alberto Bardelli, Carmen Criscitiello, et al.
Cancers
|
September 13, 2025
KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open Challenges
Pietro Paolo Vitiello, Anna Amela Valsecchi, Eleonora Duregon, et al.
Page
of 29